Y-Biologics (338840.KQ) — Stock Score Summary

Y-Biologics (338840.KQ) has a MoatMap StockRank of 7/100 based on Quality (24/100), Value (34/100), and Momentum (28/100) factor scores. The current signal is STRONG SELL.

Y-Biologics, Inc., an antibody therapeutics development company, engages in the research and development of immuno-oncology drugs and antibody drugs. The company develops YBL-006, a PD-1 immune-oncology agent that is phase 1 clinical stage for the treatment of solid tumor.

Key Financial Metrics

Price$8.87
Market Cap$136M
Price/Book7.58
Return on Equity-222.0%
Return on Invested Capital-74.7%
Debt/Equity69.72
Gross Margin78.5%
Operating Margin-1376.4%
Revenue Growth-30.8%
Free Cash Flow$-3K

Y-Biologics operates in the Biotechnology industry, part of the Healthcare sector (South Korea).

Frequently Asked Questions

What is Y-Biologics’s (338840.KQ) StockRank?
MoatMap’s StockRank for Y-Biologics (338840.KQ) is 7/100, with a Strong Sell signal. It is a composite of Quality (24), Value (34), and Momentum (28) factor ranks across MoatMap’s 19,000+ stock universe.
Does Y-Biologics have an economic moat?
Y-Biologics (338840.KQ) has a Quality factor score of 24/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Y-Biologics a buy, hold, or sell?
MoatMap’s current signal for Y-Biologics (338840.KQ) is Strong Sell, based on a StockRank of 7/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Y-Biologics in?
Y-Biologics (338840.KQ) operates in the Healthcare sector, specifically the Biotechnology industry (South Korea).
Browse all ranked stocks338840.KQ deep dive reportAI ChampionsHow we score stocksSense-check another stock